Altimmune's pemvidutide shows strong Phase IIb results for MASH, promising Phase III prospects. Read here for more analysis ...

A meta-analysis finds that mobile health tools, such as apps and text messages, support weight management and improve liver enzyme levels in patients with NAFLD.

Some trials show modest improvements in fasting glucose, lipids, or inflammatory markers, possibly via antioxidant or ...

Baricitinib was generally well-tolerated. Acne was the most common adverse event (17.6%), followed by dyslipidemia (7.8%). Asthenia, elevated liver enzymes, and weight gain each occurred in fewer than ...

Could diabetes medications have an influence beyond simply regulating blood sugar? This question is gaining ground in laboratories, where it is being asked whether these treatments are also ...

BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 Pharmaceutical Technology Excellence Awards.

Background The growing population of patients with adult congenital heart disease (ACHD) present complex lifelong care needs ...

Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...

Roche researchers have set out how patient-derived organoids, automation and high-content imaging have combined within the ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Given the success of the previous collection, <a href=" Diagnostics and Biomarker Discovery in Endocrinology and Biomedical Sciences, we are pleased to announce the launch of Volume ...

Brandi Jones has over two decades of experience as a nurse in an acute care setting. Her clinical background includes pediatrics, medical-surgical, and women's health. She also specializes in ...